CORDIS
EU research results

CORDIS

English EN

Advancing and strengthening the methodological tools and practices relating to the application and implementation of Health Technology Assessment (HTA)

Objective

"The use of HTA has increased recently in Europe and more widely (e.g. Americas) to enable evidence-based coverage decisions and improve efficiency in resource allocation.
HTA has often resulted in different coverage decisions across settings despite the same evidence being used for this purpose. This may reflect in part societal preferences about value, priorities or risk perceptions, suggesting a significant need for methodological improvements and extensions.
The fundamental objective of ADVANCE_HTA is to contribute to advancements in the methods for HTA in European and other settings by involving the wider stakeholder community in areas actively and heavily debated given their implications for decision-making and resource allocation, as follows:
• First, the issue around value for money and the different approaches surrounding current thresholds for resource allocation;
• Second, the concept of value assessment, and the factors that need to be considered beyond cost effectiveness, such as disease severity;
• Third, to improve the quality of the evidence required for and the methods associated with the assessment of rare diseases;
• Fourth, to advance the debate in the elicitation of preferences by deriving these in more realistic settings within the patient community in the wider EU;
• Fifth, to advance the debate on the suitability of current HTA tools across different categories of medical devices (e.g. diagnostics); and
• Sixth, to improve the implementation and capacity building of HTA including outside Europe, where HTA is considered explicitly in decision-making.
ADVANCE_HTA aims to broaden the spectrum, complement and address areas of intense methodological debate in the application, use and implementation of HTA. It also aims to improve HTA methods, which can be taken further by competent authorities nationally whilst supplementing the work of supra-national bodies (e.g. EUnetHTA) towards a common understanding of choices in health care decision-making."
Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Coordinator

LONDON SCHOOL OF ECONOMICS AND POLITICAL SCIENCE

Address

Houghton Street 1
Wc2a 2ae London

United Kingdom

Activity type

Higher or Secondary Education Establishments

EU Contribution

€ 825 355,95

Administrative Contact

Milena Vasileva (Ms.)

Participants (12)

Sort alphabetically

Sort by EU Contribution

Expand all

LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER

United Kingdom

EU Contribution

€ 233 640

ISTITUTO SUPERIORE DI SANITA

Italy

EU Contribution

€ 198 000

UNIVERSIDAD DE CASTILLA - LA MANCHA

Spain

EU Contribution

€ 261 760

INSTITUT ZA EKONOMSKA RAZISKOVANJA

Slovenia

EU Contribution

€ 192 960

TECHNISCHE UNIVERSITAT BERLIN

Germany

EU Contribution

€ 422 080

ESCUELA ANDALUZA DE SALUD PUBLICA SA

Spain

EU Contribution

€ 282 094,20

PAN AMERICAN HEALTH ORGANIZATION

United States

EU Contribution

€ 175 947,20

THE EUROPEAN BRAIN COUNCIL AISBL

Belgium

EU Contribution

€ 98 760

UNIVERSITE PARIS XII VAL DE MARNE

France

EU Contribution

€ 77 120

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE

United Kingdom

EU Contribution

€ 146 617,25

AGENCJA OCENY TECHNOLOGII MEDYCZNYCH I TARYFIKACJI

Poland

EU Contribution

€ 56 160,40

TANDVARDS-OCH LAKEMEDELSFORMANSVERKET

Sweden

EU Contribution

€ 29 310

Project information

Grant agreement ID: 305983

Status

Closed project

  • Start date

    1 January 2013

  • End date

    31 December 2015

Funded under:

FP7-HEALTH

  • Overall budget:

    € 4 035 099,15

  • EU contribution

    € 2 999 805

Coordinated by:

LONDON SCHOOL OF ECONOMICS AND POLITICAL SCIENCE

United Kingdom